Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin®)

Vox Sanguinis

Volumn 90, Issue 4, 2006, Pages 294-301

  Schellongowski, Peter ^a   Bauer, Edith ^a   Holzinger, Ulrike ^a   Staudinger, Thomas ^a   Frass, Michael ^a   Laczika, Klaus ^a   Locker, Gottfried J ^a   Quehenberger, Peter ^a   Rabitsch, Werner ^a   Schenk, Peter ^a   Knöbl, Paul ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Disseminated intravascular coagulation; Hypercoagulability; Protein C; Purpura fulminans; Sepsis

Indexed keywords

ALTEPLASE; ANTITHROMBIN; D DIMER; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; PROTEIN C;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BOLUS INJECTION; CANDIDIASIS; CLINICAL ARTICLE; COMPARTMENT SYNDROME; DEATH; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FEMALE; FULMINATING PURPURA; HUMAN; HYPERCOAGULABILITY; INJECTION SITE BLEEDING; KIDNEY FAILURE; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RESPIRATORY FAILURE; SEPSIS; SEPTIC SHOCK; THROMBOCYTE TRANSFUSION; THROMBOSIS;

ADOLESCENT; ADULT; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROTEIN C; PURPURA, SCHOENLEIN-HENOCH; SEPSIS; TREATMENT OUTCOME;

EID: 33646082484     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00760.x     Document Type: Article

References (33)

1. Levi M ten Cate H van der Poll T van Deventer SJ Pathogenesis of disseminated intravascular coagulation in sepsis JAMA 1993 270 975 979
2. Levi M van der Poll T ten Cate H van Deventer SJ The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia Eur J Clin Invest 1997 27 3 9
3. Shimamura K Oka K Nakazawa M Kojima M Distribution patterns of microthrombi in disseminated intravascular coagulation Arch Pathol Lab Med 1983 107 543 547
4. Levi M van der Poll T de Jonge E ten Cate H Relative insufficiency of fibrinolysis in disseminated intravascular coagulation Sepsis 2000 3 103 109
5. Levi M de Jonge E van der Poll T ten Cate H Disseminated intravascular coagulation: state of the art Thromb Haemost 1999 82 695 705
6. Levi M ten Cate H Disseminated intravascular coagulation N Engl J Med 1999 341 586 592
7. Fourrier F Chopin C Goudemand J Hendrycx S Caron C Rime A Marey A Lestavel P Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies Chest 1992 101 816 823
8. Fijnvandraat K Derkx B Peters M Bijlmer R Sturk A Prins MH van Deventer SJ ten Cate JW Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality Thromb Haemost 1995 73 15 20
9. Esmon CT Role of coagulation inhibitors in inflammation Thromb Haemost 2001 86 51 56
10. Mesters RM Helterbrand J Utterback BG Yan B Chao YB Fernandez JA Griffin JH Hartman DL Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications Crit Care Med 2000 28 2209 1613
11. Yan SB Helterbrand JD Hartman DL Wright TJ Bernard GR Low levels of Protein C are associated with poor outcome in severe sepsis Chest 2001 120 915 922
12. Gerson WT Dickermann JD Bovill EG Golden E Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate Pediatrics 1993 91 418 422
13. Rivard GE David M Farrell C Schwarz HP Treatment of purpura fulminans in meningococcemia with protein C concentrate J Pediatr 1995 126 646 652
14. Smith OP White B Vaughan D Rafferty M Claffey L Lyons B Casey W Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans Lancet 1997 350 1590 1593
15. Kreuz W Veldmann A Escuriola-Ettingshausen C Schneider W Beeg T Protein-C concentrate for meningococcal purpura fulminans Lancet 1998 351 986 987
16. Rintala E Seppala OP Kotilainen P Petitila V Rasi V Protein C in the treatment of coagulopathy in meningococcal disease Crit Care Med 1998 26 965 968
17. Ettingshausen CE Veldmann A Beeg T Scheider W Jager G Kreuz W Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans Semin Thromb Hemost 1999 25 537 541
18. Clarke RC Johnston JR Mayne EE Meningococcal septicaemia: treatment with protein C concentrate Intensive Care Med 2000 26 471 473
19. Rintala E Kauppila M Seppiala OP Voipio-Pulkki LM Pettila V Rasi V Kotilainen P Protein C substitution in sepsis-associated purpura fulminans Crit Care Med 2000 28 2373 2378
20. White B Livingstone W Murphy C Hodgson A Rafferty M Smith OP An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia Blood 2000 96 3719 3724
21. de Kleijn ED de Groot R Hack CE Mulder PG Engl W Moritz B Joosten KF Hazelzet JA Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study Crit Care Med 2003 31 1839 1847
22. Bone RC Balk RA Cerra FB Dellinger RP Fein AM Knaus WA Schein RM Sibbald WJ Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee Am College Chest Physicians/Soc Crit Care Med Chest 1992 101 1644 1655
23. Rivers E Nguyen B Havstad S Ressler J Muzzin A Knoblich B Peterson E Tomlanovich M Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 2001 345 1368 1377
24. Briegel J Forst H Haller M Schelling G Kilger E Kuprat G Hemmer B Hummel T Lenhart A Heyduck M Stoll C Peter K Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study Crit Care Med 1999 27 723 732
25. Annane D Sebille V Charpentier C Bollaert PE Francois B Korach JM Capellier G Cohen Y Azoulay E Troche G Chaumet-Riffaut P Bellissant E Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 2002 288 862 871
26. Taylor FB Jr. Toh CH Hoots WK Wada H Levi M Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Thromb Haemost 2001 86 1327 1330
27. Zenz W Bodo Z Zobel G Fanconi S Rettenbacher A Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans Crit Care Med 1998 26 969 971
28. Leclerc F Cremer R Leteurtre S Martinot A Fourier C Protein C concentrate and recombinant tissue plasminogen activator in meningococcal septic shock Crit Care Med 2000 28 1694 1697
29. Fourrier F Leclerc F Aidan K Sadik A Jourdain M Tournoys A Noizet O Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study Intensive Care Med 2003 29 1081 1087
30. Sinclair JF Skeoch CH Hallworth D Prognosis of meningococcal septicaemia Lancet 1987 2 38
31. Bernard GR Vincent JL Laterre PF La Rosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW Fisher CJ Jr. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 2001 344 699 709
32. Dhainaut JF Yan SB Joyce DE Pettila V Basson B Brandt JT Sundin DP Levi M Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation J Thromb Haemost 2004 2 1924 1933
33. Van den Berghe G Wouters P Weekers F Verwaest C Bruyninckx F Schetz M Vlasselaers D Ferdinande P Lauwers P Bouillon R Intensive insulin therapy in the critically ill patients N Engl J Med 2001 345 1359 1367